Genetically Corrected iPSC-Derived Neural Stem Cell Grafts Deliver Enzyme Replacement to Affect CNS Disease in Sanfilippo B Mice.
Genetically Corrected iPSC-Derived Neural Stem Cell Grafts Deliver Enzyme Replacement to Affect CNS Disease in Sanfilippo B Mice.
复制标题
DOI:
10.1016/j.omtm.2018.06.005
复制
发表时间:
2018-09-21
期刊:
影响因子:
--
通讯作者:
Iacovino M
中科院分区:
文献类型:
--
作者:
Clarke D;Pearse Y;Kan SH;Le SQ;Sanghez V;Cooper JD;Dickson PI;Iacovino M
Sanfilippo syndrome type B (mucopolysaccharidosis type IIIB [MPS IIIB]) is a lysosomal storage disorder primarily affecting the brain that is caused by a deficiency in the enzyme α-N-acetylglucosaminidase (NAGLU), leading to intralysosomal accumulation of heparan sulfate. There are currently no treatments for this disorder. Here we report that, ex vivo, lentiviral correction of Naglu−/− neural stem cells derived from Naglu−/− mice (iNSCs) corrected their lysosomal pathology and allowed them to secrete a functional NAGLU enzyme that could be taken up by deficient cells. Following long-term transplantation of these corrected iNSCs into Naglu−/− mice, we detected NAGLU activity in the majority of engrafted animals. Successfully transplanted Naglu−/− mice showed a significant decrease in storage material, a reduction in astrocyte activation, and complete prevention of microglial activation within the area of engrafted cells and neighboring regions, with beneficial effects extending partway along the rostrocaudal axis of the brain. Our results demonstrate long-term engraftment of iNSCs in the brain that are capable of cross-correcting pathology in Naglu−/− mice. Our findings suggest that genetically engineered iNSCs could potentially be used to deliver enzymes and treat MPS IIIB.
登录
查看更多内容
影响因子:
3.7
作者:
Ausseil, Jerome;Desmaris, Nathalie;Bigou, Stephanie;Attali, Ruben;Corbineau, Sebastien;Vitry, Sandrine;Parent, Mathieu;Cheillan, David;Fuller, Maria;Maire, Irene;Vanier, Marie-Therese;Heard, Jean-Michel
通讯作者:
Heard, Jean-Michel
DOI:
10.1073/pnas.1416660111
发表时间:
2014-10-14
影响因子:
11.1
作者:
Kan, Shih-hsin;Aoyagi-Scharber, Mika;Neufeld, Elizabeth F.
通讯作者:
Neufeld, Elizabeth F.
影响因子:
158.5
作者:
Kakkis, ED;Muenzer, J;Thompson, JN
通讯作者:
Thompson, JN
影响因子:
158.5
作者:
BARTON, NW;BRADY, RO;YU, KT
通讯作者:
YU, KT
DOI:
10.1016/j.omtm.2017.05.009
发表时间:
2017-09-15
期刊:
Molecular therapy. Methods & clinical development
影响因子:
--
作者:
Aoyagi-Scharber M;Crippen-Harmon D;Lawrence R;Vincelette J;Yogalingam G;Prill H;Yip BK;Baridon B;Vitelli C;Lee A;Gorostiza O;Adintori EG;Minto WC;Van Vleet JL;Yates B;Rigney S;Christianson TM;Tiger PMN;Lo MJ;Holtzinger J;Fitzpatrick PA;LeBowitz JH;Bullens S;Crawford BE;Bunting S
通讯作者:
Bunting S